Where Are T Cell Engagers & Multispecifics Heading? Explore the Data
Bispecifics continue to evolve at pace, with growing activity across T cell engagers and multispecific ADCs reshaping both clinical development and commercial strategy.
This slide deck, presented by Beacon’s bispecific analyst, Longli Zhou, provides a direct view of the data shared on-site, highlighting key trends, pipeline dynamics, and emerging opportunities across the space.
The slides offer a rich, visual snapshot of how the landscape is developing, enabling you to quickly interpret where momentum is building.
What the slides cover:
- A high-level overview of bispecific and multispecific modalities, illustrating how formats and targets continue to diversify.
- Data-led snapshots of the T cell engager landscape, including pipeline activity, clinical progress, and commercial momentum.
- Visual breakdowns of multispecific ADC development, where rising competition is driving innovation and differentiation.
- Key charts and figures presented live at the summit, offering a shareable, data-first view of emerging trends.
You May Also Be Interested In…
Learn More About Bispecific
- The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
- Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
